Skip to main content
SpringerLink
Log in

Management des Syndroms polyzystischer Ovarien in der Peri- und Postmenopause

Management of polycystic ovary syndrome in perimenopausal and postmenopausal women

  • Menopause und Frauengesundheit
  • Published:
Gynäkologische Endokrinologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Azziz R, Marin C, Hoq L, Badamgarav E, Song P (2005) Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 90(8):4650–4658

    Article  CAS  PubMed  Google Scholar 

  2. The Rotterdam ESHRE/ASRM‐sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47

    Article  Google Scholar 

  3. Panda PK, Rane R, Ravichandran R, Singh S, Panchal H (2016) Genetics of PCOS: A systematic bioinformatics approach to unveil the proteins responsible for PCOS. Genom Data 8:52–60

    Article  PubMed  PubMed Central  Google Scholar 

  4. Minooee S et al (2018) Predicition of age at menopause in women with polycystic ovarian syndrome. Climacteric 21(1):29–34

    Article  CAS  PubMed  Google Scholar 

  5. Yin O et al (2018) Association between polycystic ovary syndrome and hot flash presentation during the midlife period. Menopause 25(6):691–696. https://doi.org/10.1097/GME.0000000000001055

    Article  PubMed  Google Scholar 

  6. Jaliseh K et al (2017) Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study. Fertil Steril 108:1078–1084

    Article  Google Scholar 

  7. Mumusoglu S et al (2018) Metabolic syndrome during menopause. Curr Vasc Pharmacol. https://doi.org/10.2174/1570161116666180904094149

    Article  Google Scholar 

  8. Harris HR, Titus LJ, Cramer DW, Terry KL (2017) Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study. Int J Cancer 140(2):285–291

    Article  CAS  PubMed  Google Scholar 

  9. Barry JA, Azizia MA, Hardiman PJ (2014) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 20(5):748–758

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung gynäkologische Endokrinologie und Reproduktionsmedizin, Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland

    Annette Bachmann

Authors
  1. Annette Bachmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Annette Bachmann.

Ethics declarations

Interessenkonflikt

A. Bachmann gibt an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von der Autorin keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Redaktion

L. Kiesel, Münster

A.O. Mueck, Tübingen

P. Stute, Bern

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bachmann, A. Management des Syndroms polyzystischer Ovarien in der Peri- und Postmenopause. Gynäkologische Endokrinologie 17, 288–290 (2019). https://doi.org/10.1007/s10304-019-00272-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-019-00272-3

Search

Navigation